Trial Profile
Single-institution Case-series Analysis on the Addition of the Sufentanil NanoTab PCA System/15 mcg (Zalviso) to a Multimodal Analgesic Regimen in Vertebral Surgery: A Preliminary Investigation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2019
Price :
$35
*
At a glance
- Drugs Sufentanil (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 10 Mar 2019 Status changed from not yet recruiting to completed.
- 14 Mar 2018 New trial record